2 news items
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VIR
22 Feb 24
Long
Earnings Outlook For Vir Biotechnology
VIR
21 Feb 24
are down 59.94%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release
- Prev
- 1
- Next